www.law360.com/cases/5c33d32753053053d100b9bd

Parties, docket activity and news coverage of federal case Mead v. Janssen Research & Development LLC et al, case number 2:19-cv-00106, from Louisiana  ...

caselaw.findlaw.com/pa-superior-court/1889831.html

JANSSEN PHARMACEUTICALS INC JOHNSON JOHNSON JANSSEN ... RESEARCH AND DEVELOPMENT, LLC NICHOLAS MURRAY, Appellant v. ... All of the cases in this mass tort action consist of male plaintiffs who allege they ..... the size of his penis, I know that he has completed his puberty as an adult young man.

caselaw.findlaw.com/pa-superior-court/1885246.html

JANSSEN PHARMACEUTICALS INC JOHNSON JOHNSON JANSSEN RESEARCH ... and Janssen Research & Development, LLC, have taken cross- appeals from the ... All of the cases in this mass tort involve male plaintiffs who allege they ..... He is familiar with gynecomastia and has diagnosed and operated on young ...

sheller.com/jury-awards-500000-in-risperdal-trial

Dec 11, 2015 ... ... jury awarded $500000 in compensatory damages to a young man who ... V.S, et al. v. ... Janssen Pharmaceuticals Inc., Johnson & Johnson Company, and Janssen Pharmaceutical Research and Development, LLC., no.

www.pacermonitor.com/court/133/Louisiana_Eastern_District_Court

Janssen Research & Development LLC et al Court: Louisiana Eastern District ..... Young v. Sanofi US Services Inc. et al Court: Louisiana Eastern District Court

www.industrydocumentslibrary.ucsf.edu/drug/collections/risperdal-litigation-documents

Camille McGowan and Judy Doetterl v Janssen Pharmaceutical Products, LP, ... Johnson Company and Janssen Pharmaceutical Research and Development, LLC ... Johnson & Johnson Company, Janssen Pharmaceutical Products, et al. ... harmful side effects such as the development of gynecomastia in young men.

www.researchgate.net/profile/Pilar_Lim

Pilar Lim of Janssen Research & Development, LLC, Raritan (JANSSEN). ... of the ET classification are described in terms of sensitivity and specificity versus the .... Results At all esketamine doses (28 mg, 56 mg, 84 mg), subjects reported a ..... Patients experiencing a manic or mixed episode (Young Mania Rating Scale  ...

www.janssen.com/invokana-canagliflozin-demonstrates-cardiovascular-cv-risk-reductions-type-2-diabetes-patients-and

Nov 14, 2017 ... “All people with type 2 diabetes have an increased risk of developing ... Primary prevention participants (N=3486; 34%) were younger (63 vs 64 years), more often .... expectations and projections of Janssen Research & Development, LLC, any of ... [1] Lavalle-Gonzalez F, Januszewicz A, Davidson J, et al.

www.janssen.com/new-phase-3-data-show-esketamine-nasal-spray-demonstrated-rapid-improvements-depressive-symptoms

May 5, 2018 ... TITUSVILLE, N.J., May 5, 2018 – The Janssen Pharmaceutical Companies of ... Therapeutic Area, Janssen Research & Development, LLC. ... an oral antidepressant vs. placebo nasal spray plus an oral antidepressant, ... with previous studies of esketamine in younger adult populations. .... Khin NA, et.al.